Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 325

1.

Hand-foot skin reaction predicts treatment outcome of pazopanib in patients with metastatic soft tissue sarcoma: A multicenter study in the Asian population.

Huang PW, Chou WC, Shen WC, Hung CY, Huang KG, Su YL, Lu CH, Liu CT, Chang YS, Liau CT.

Asia Pac J Clin Oncol. 2018 Jun 13. doi: 10.1111/ajco.13029. [Epub ahead of print]

PMID:
29900662
2.

Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information.

Tefferi A, Gangat N, Mudireddy M, Lasho TL, Finke C, Begna KH, Elliott MA, Al-Kali A, Litzow MR, Hook CC, Wolanskyj AP, Hogan WJ, Patnaik MM, Pardanani A, Zblewski DL, He R, Viswanatha D, Hanson CA, Ketterling RP, Tang JL, Chou WC, Lin CC, Tsai CH, Tien HF, Hou HA.

Mayo Clin Proc. 2018 Jun 1. pii: S0025-6196(18)30312-4. doi: 10.1016/j.mayocp.2018.04.013. [Epub ahead of print]

PMID:
29866419
3.

Factors associated with the prognosis and long-term survival of patients with metastatic lung adenocarcinoma: a retrospective analysis.

Huang CY, Chen BH, Chou WC, Yang CT, Chang JW.

J Thorac Dis. 2018 Apr;10(4):2070-2078. doi: 10.21037/jtd.2018.03.143.

4.

Quality of Life and Psychological Distress Are Differentially Associated with Distinct Symptom-Functional States in Terminally Ill Cancer Patients' Last Year of Life.

Wen FH, Chen JS, Chou WC, Hsieh CH, Chang WC, Shen WC, Tang ST.

Psychooncology. 2018 May 25. doi: 10.1002/pon.4775. [Epub ahead of print]

PMID:
29802650
5.

Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA.

Tien FM, Hou HA, Tang JL, Kuo YY, Chen CY, Tsai CH, Yao M, Lin CT, Li CC, Huang SY, Ko BS, Hsu SC, Wu SJ, Liu JH, Chou SC, Tsay W, Tseng MH, Liu MC, Liu CW, Lin LI, Chou WC, Tien HF.

Haematologica. 2018 May 17. pii: haematol.2018.189043. doi: 10.3324/haematol.2018.189043. [Epub ahead of print] No abstract available.

6.

Gut microbiota utilize immunoglobulin A for mucosal colonization.

Donaldson GP, Ladinsky MS, Yu KB, Sanders JG, Yoo BB, Chou WC, Conner ME, Earl AM, Knight R, Bjorkman PJ, Mazmanian SK.

Science. 2018 May 18;360(6390):795-800. doi: 10.1126/science.aaq0926. Epub 2018 May 3.

PMID:
29724905
7.

SUMOylation of XRCC1 activated by poly (ADP-ribosyl)ation regulates DNA repair.

Hu LY, Chang CC, Huang YS, Chou WC, Lin YM, Ho CC, Chen WT, Shih HM, Hsiung CN, Wu PE, Shen CY.

Hum Mol Genet. 2018 Jul 1;27(13):2306-2317. doi: 10.1093/hmg/ddy135.

PMID:
29668892
8.

Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients.

Tien FM, Hou HA, Tsai CH, Tang JL, Chen CY, Kuo YY, Li CC, Lin CT, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Tseng MH, Liu MC, Liu CW, Lin LI, Chou WC, Tien HF.

Eur J Haematol. 2018 Jul;101(1):86-94. doi: 10.1111/ejh.13073. Epub 2018 May 22.

PMID:
29624746
9.

Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome.

Lin ME, Hou HA, Tsai CH, Wu SJ, Kuo YY, Tseng MH, Liu MC, Liu CW, Chou WC, Chen CY, Tang JL, Yao M, Li CC, Huang SY, Ko BS, Hsu SC, Lin CT, Tien HF.

Clin Epigenetics. 2018 Apr 2;10:42. doi: 10.1186/s13148-018-0476-1. eCollection 2018.

10.

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.

Hou HA, Tsai CH, Lin CC, Chou WC, Kuo YY, Liu CY, Tseng MH, Peng YL, Liu MC, Liu CW, Liao XW, Lin LI, Yao M, Tang JL, Tien HF.

Blood Cancer J. 2018 Apr 4;8(4):39. doi: 10.1038/s41408-018-0074-7.

11.

Distinct Patterns of Conjoint Symptom Distress and Functional Impairment in the Last Year of Life Predict Terminally Ill Cancer Patients' Survival.

Wen FH, Chen JS, Chou WC, Hsieh CH, Chang WC, Hou MM, Tang ST.

J Pain Symptom Manage. 2018 Jun;55(6):1443-1451.e2. doi: 10.1016/j.jpainsymman.2018.03.007. Epub 2018 Mar 13.

PMID:
29545065
12.

A Prognostic Model Based on Circulating Tumour Cells is Useful for Identifying the Poorest Survival Outcome in Patients with Metastatic Colorectal Cancer.

Chou WC, Wu MH, Chang PH, Hsu HC, Chang GJ, Huang WK, Wu CE, Hsieh JC.

Int J Biol Sci. 2018 Jan 12;14(2):137-146. doi: 10.7150/ijbs.23182. eCollection 2018.

13.

The dynamics of a dominant dinoflagellate, Noctiluca scintillans, in the subtropical coastal waters of the Matsu archipelago.

Tsai SF, Wu LY, Chou WC, Chiang KP.

Mar Pollut Bull. 2018 Feb;127:553-558. doi: 10.1016/j.marpolbul.2017.12.041. Epub 2017 Dec 22.

14.

ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study.

Chen CJ, Tseng CC, Yen JH, Chang JG, Chou WC, Chu HW, Chang SJ, Liao WT.

Sci Rep. 2018 Feb 16;8(1):3137. doi: 10.1038/s41598-018-21425-7.

15.

Detection of membrane protein-protein interaction in planta based on dual-intein-coupled tripartite split-GFP association.

Liu TY, Chou WC, Chen WY, Chu CY, Dai CY, Wu PY.

Plant J. 2018 May;94(3):426-438. doi: 10.1111/tpj.13874. Epub 2018 Mar 23.

PMID:
29451720
16.

Elevated particulate organic carbon export flux induced by internal waves in the oligotrophic northern South China Sea.

Li D, Chou WC, Shih YY, Chen GY, Chang Y, Chow CH, Lin TY, Hung CC.

Sci Rep. 2018 Feb 1;8(1):2042. doi: 10.1038/s41598-018-20184-9.

17.

Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan.

Chen CY, Tien FM, Cheng A, Huang SY, Chou WC, Yao M, Tang JL, Tien HF, Sheng WH.

BMC Gastroenterol. 2018 Jan 8;18(1):6. doi: 10.1186/s12876-017-0735-1.

18.

A 4-lncRNA scoring system for prognostication of adult myelodysplastic syndromes.

Yao CY, Chen CH, Huang HH, Hou HA, Lin CC, Tseng MH, Kao CJ, Lu TP, Chou WC, Tien HF.

Blood Adv. 2017 Aug 16;1(19):1505-1516. doi: 10.1182/bloodadvances.2017008284. eCollection 2017 Aug 22.

19.

Adjuvant Chemotherapy Improves Survival in Stage III Gastric Cancer after D2 Surgery.

Chang SC, Liu KH, Hung CY, Tsai CY, Hsu JT, Yeh TS, Chen JS, Kuo YC, Hung YS, Chou WC.

J Cancer. 2018 Jan 1;9(1):81-91. doi: 10.7150/jca.21989. eCollection 2018.

20.

Accurate Prognostic Awareness Facilitates, Whereas Better Quality of Life and More Anxiety Symptoms Hinder End-of-Life Care Discussions: A Longitudinal Survey Study in Terminally Ill Cancer Patients' Last Six Months of Life.

Tang ST, Chen CH, Wen FH, Chen JS, Chang WC, Hsieh CH, Chou WC, Hou MM.

J Pain Symptom Manage. 2018 Apr;55(4):1068-1076. doi: 10.1016/j.jpainsymman.2017.12.485. Epub 2017 Dec 29.

PMID:
29289656

Supplemental Content

Support Center